Lisa Schopf, PhD
Lisa is an experienced preclinical research professional with expertise in both small molecules and biologic agents. Her broad drug development background spans both small biotechnology and large pharma settings. She has had leadership roles in transitioning projects from early discovery into development with over 20 years of experience in the pharmaceutical industry focused in inflammatory diseases, immunology, and pharmacology.
Lisa is currently the Vice President/Head of Preclinical Development at Vedanta Biosciences focused on pioneering a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system. She has previously served as the Senior Director of Preclinical Development at clinical-stage pharmaceutical company Kala Pharmaceuticals. She has worked at Virdante Pharmaceuticals, Abbott Bioresearch Center, Millennium Pharmaceuticals as well as Genetics Institute. Lisa received her B.S. in Biology/Chemistry from Carroll College, her M.S. in Bacteriology and her Ph.D. in Immunology from the University of Wisconsin-Madison.
Lisa has been a board member of the Inflammation Research Association since 2004, and served as Secretary (2010-2012), Treasurer (2012-2014) , Vice President (2014-2016) and is currently the President.